24 results
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
direct-acting antivirals ... (DAAs) for chronic ... #DAAs #Antivirals ... HepatitisC #Management #Pharmacology
Guide to Treatment of Hepatitis C with Direct Acting Antivirals.

Here is a pocket guide to initial
Direct Acting Antivirals ... treatment of HCV with DAAs ... #Management #Pharmacology ... HepatitisC #HCV #DAA ... #DirectActing #Antivirals
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Preventing and Treating Bacterial ... HIV-AIDS Preventing Bacterial ... day for 10–14 days ... opportunistic #infections #HIVAIDS ... #pharmacology
This is an overview of the 3 main drug classes used to treat Hepatitis C

The new
Direct-Acting Antivirals ... Nomenclature #Classes #DAAs ... #Pharmacology
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Indications and Pharmacology ... increases venous & arterial ... #Indications #Pharmacology ... #hematology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
., 4 mg/kg on days ... mg/kg every 21 days ... IV daily for 10 days ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Therapy: 7–14 days ... Therapy: 14–21 days ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
doses for 30–60 days ... PO for 90–120 days ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IV) QID for 10 days ... ) BID for 7–10 days ... mg PO BID for 7 days ... opportunistic #infections #HIVAIDS ... #pharmacology
Blood Transfusion Reactions

Immune Mediated:
 • Febrile Non-Hemolytic Transfusion Reaction (FNHTR): Most common immune reaction to transfusion.
24 hours to 30 days ... ): Occurs 7-10 days ... very rare), or bacterial ... • Bacterial contamination ... diagnosis #management #hematology